Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Tramadol for the management of premature ejaculation: a timely systematic review

International Journal of Impotence Research volume 27, pages 121–127 (2015)Cite this article

Subjects

Abstract

Premature ejaculation (PE) represents a common sexual dysfunction and is associated with a negative impact on quality of life and relationships. Recent evidence suggests that on-demand dosing of tramadol is effective at increasing intra-vaginal ejaculatory latency time (IELT) and improving subjective measures of satisfaction. A literature review was performed of journal articles published between January 2000 and July 2014 that matched the keywords 'tramadol' and 'premature ejaculation'. We identified eight relevant articles with the criteria that each article be published in a peer-reviewed journal, represent original work and be written in English. IELT was used as the primary outcome in each of the papers reviewed for efficacy. Additional subjective outcome measures were reviewed where available. Safety was assessed using adverse event data from the individual studies. We found that tramadol in on-demand dosing is effective at lengthening IELT in men with varying degrees of PE and improves patient satisfaction. Tramadol was generally well tolerated, particularly among those taking 25 and 50 mg doses. Although there is a risk of abuse and dependence, these events are rare, particularly at low doses taken intermittently. In conclusion, tramadol is an effective oral therapy for PE that is overall safe and well tolerated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J . The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol 2007; 51: 816–823, discussion 824.

    Article  Google Scholar 

  2. Rosen RC, Althof S . Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequences. J Sex Med 2008; 5: 1296–1307.

    Article  Google Scholar 

  3. Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med 2014; 11: 1423–1441.

    Article  Google Scholar 

  4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, text rev. edn. American Psychiatric Association: Washington, DC, USA, 2000.

  5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. American Psychiatric Association: Washington, DC, USA, 2013.

  6. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004; 172: 290–294.

    Article  Google Scholar 

  7. Henry R, Morales A . Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study. Int J Impot Res 2003; 15: 277–281.

    Article  CAS  Google Scholar 

  8. Morales A, Barada J, Wyllie MG . A review of the current status of topical treatments for premature ejaculation. BJU Int 2007; 100: 493–501.

    Article  CAS  Google Scholar 

  9. Jannini EA, McMahon C, Chen J, Aversa A, Perelman M . The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J Sex Med 2011; 8: 2135–2143.

    Article  Google Scholar 

  10. Safarinejad MR, Hosseini SY . Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. J Clin Psychopharmacol 2006 Feb; 26: 27–31.

    Article  CAS  Google Scholar 

  11. Bar-Or D, Salottolo KM, Orlando A, Winkler JV, Tramadol ODT Study Group. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur Urol 2012; 61: 736–743.

    Article  CAS  Google Scholar 

  12. Kim SC, Seo KK . Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urol 1998; 159: 425–427.

    Article  CAS  Google Scholar 

  13. Frink MC, Hennies HH, Englberger W, Haurand M, Wilffert B . Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung 1996; 46: 1029–1036.

    CAS  PubMed  Google Scholar 

  14. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993; 267: 331–340.

    CAS  PubMed  Google Scholar 

  15. Jou IM, Chu KS, Chen HH, Chang PJ, Tsai YC . The effects of intrathecal tramadol on spinal somatosensory-evoked potentials and motor-evoked responses in rats. Anesth Analg 2003; 96: 783–788.

    Article  CAS  Google Scholar 

  16. Alghobary M, El-Bayoumy Y, Mostafa Y, Mahmoud EM, Amr M . Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation. J Sex Med 2010; 7: 2860–2867.

    Article  CAS  Google Scholar 

  17. Eassa BI, El-Shazly MA . Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation. Asian J Androl 2013; 15: 138–142.

    Article  CAS  Google Scholar 

  18. Eid MA, Ahmed HH, Ismail NN, Shehada SY . Comparative study between tramadol (50 mg) on demand and paroxitine HCl (20 mg) on demand in the treatment of premature ejaculation. Hum Androl 2011; 1: 69–73.

    Article  Google Scholar 

  19. Kaynar M, Kilic O, Yurdakul T . On-demand tramadol hydrochloride use in premature ejaculation treatment. Urology 2012; 79: 145–149.

    Article  Google Scholar 

  20. Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleves MA . Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med 2008; 5: 188–193.

    Article  CAS  Google Scholar 

  21. Khan AH, Rasaily D . Tramadol use in premature ejaculation: daily versus sporadic treatment. Indian J Psychol Med 2013; 35: 256–259.

    Article  Google Scholar 

  22. Giuliano F . 5-Hydroxytryptamine in premature ejaculation: opportunities for therapeutic intervention. Trends Neurosci 2007; 30: 79–84.

    Article  CAS  Google Scholar 

  23. Giuliano F, Clement P . Serotonin and premature ejaculation: from physiology to patient management. Eur Urol 2006; 50: 454–466.

    Article  CAS  Google Scholar 

  24. McMahon C . Premature ejaculation: past, present, and future perspectives. J Sex Med 2005; 2: 94–95.

    Article  Google Scholar 

  25. Xiong GG, Wu FH, Chen SH, Yao WL . Safety and efficacy of tramadol hydrochloride with behavioral modification in the treatment of premature ejaculation. Zhonghua Nan Ke Xue 2011; 17: 538–541.

    PubMed  Google Scholar 

  26. Palmer NR . Tramadol for premature ejaculation. J Sex Med 2009; 6: 299.

    Article  Google Scholar 

  27. Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, Strain EC . Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology (Berl) 2010; 211: 457–466.

    Article  CAS  Google Scholar 

  28. Barsotti CE, Mycyk MB, Reyes J . Withdrawal syndrome from tramadol hydrochloride. Am J Emerg Med 2003; 21: 87–88.

    Article  Google Scholar 

  29. Yates WR, Nguyen MH, Warnock JK . Tramadol dependence with no history of substance abuse. Am J Psychiatry 2001; 158: 964.

    Article  CAS  Google Scholar 

  30. Freye E, Levy J . Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram): a case study. Eur J Pain 2000; 4: 307–311.

    Article  CAS  Google Scholar 

  31. Zhang H, Liu Z . The investigation of tramadol dependence with no history of substance abuse: a cross-sectional survey of spontaneously reported cases in Guangzhou City, China. Biomed Res Int 2013; 2013: 283425.

    PubMed  PubMed Central  Google Scholar 

  32. Senay EC, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH et al. Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend 2003; 69: 233–241.

    Article  Google Scholar 

  33. Cicero TJ, Adams EH, Geller A, Inciardi JA, Munoz A, Schnoll SH et al. A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend 1999; 57: 7–22.

    Article  CAS  Google Scholar 

  34. Inciardi JA, Cicero TJ, Munoz A, Adams EH, Geller A, Senay EC et al. The diversion of ultram, ultracet, and generic tramadol HCL. J Addict Dis 2006; 25: 53–58.

    Article  Google Scholar 

  35. Wu T, Yue X, Duan X, Luo D, Cheng Y, Tian Y et al. Efficacy and safety of tramadol for premature ejaculation: a systematic review and meta-analysis. Urology 2012; 80: 618–624.

    Article  Google Scholar 

  36. Segraves RT . Considerations for an evidence-based definition of premature ejaculation in the DSM-V. J Sex Med 2010; 7: 672–679.

    Article  Google Scholar 

  37. Cossmann M, Kohnen C, Langford R, McCartney C . Tolerance and safety of tramadol use. Results of international studies and data from drug surveillance. Drugs 1997; 53: 50–62.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of North Carolina, Chapel Hill, NC, USA

    E W Kirby, C C Carson & R M Coward

Authors
  1. E W Kirby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C C Carson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R M Coward
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E W Kirby.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kirby, E., Carson, C. & Coward, R. Tramadol for the management of premature ejaculation: a timely systematic review. Int J Impot Res 27, 121–127 (2015). https://doi.org/10.1038/ijir.2015.7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2015.7

This article is cited by

Search

Advanced search

Quick links